1. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
   Rossella Cianci et al, 2019, IJMS CrossRef
2. Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism.
   Jin He et al, 2020, Int J Mol Sci CrossRef
3. Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism
   Andy W.C. Man et al, 2020, Nutrients CrossRef
4. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal Cancer
   Asimina Koulouridi et al, 2020, Cancers CrossRef
5. Dietary Organic Acids Modulate Gut Microbiota and Improve Growth Performance of Nursery Pigs
   Xiaoyuan Wei et al, 2021, Microorganisms CrossRef
6. Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
   Davide Banfi et al, 2021, IJMS CrossRef
7. The role of mucosal barriers in human gut health
   Kangseok Seo et al, 2021, Arch. Pharm. Res. CrossRef
8. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer
   Eva Pastille et al, 2021, Front. Immunol. CrossRef
9. null
   Graham A. J. Redweik et al, 2022 CrossRef
10. Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?
    Yan Lin et al, 2022, Front. Oncol. CrossRef
11. Regulation of short-chain fatty acids in the immune system
    Xiao-feng Liu et al, 2023, Front. Immunol. CrossRef
12. Polysaccharides from brown seaweed: Physicochemical properties, absorption in the intestine, and beneficial effects on intestinal barrier
    Wanzi Yao et al, 2023, Food Frontiers CrossRef
13. Disentangling the molecular mystery of tumour–microbiota interactions: Microbial metabolites
    Yu‐Fei Duan et al, 2024, Clinical & Translational Med CrossRef